3.30MMarket Cap-137P/E (TTM)
0.4700High0.4311Low170.79KVolume0.4700Open0.4618Pre Close75.98KTurnover2.31%Turnover RatioLossP/E (Static)7.59MShares2.210052wk High0.88P/B3.22MFloat Cap0.431152wk Low--Dividend TTM7.41MShs Float5757.6000Historical High--Div YieldTTM8.42%Amplitude0.4311Historical Low0.4440Avg Price1Lot Size
Ensysce Biosciences Stock Forum
Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program
Ensysce Biosciences (NASDAQ: ENSC) has achieved a critical milestone in its opioid use disorder (OUD) program. The company has selected PF9001, a lead drug candidate designed to reduce abuse potential and improve safety, particularly with lower cardiovascular risks compared to traditional treatments. The candidate will proceed to Investigational New Drug (IND) enabling studies, backed...
NEWS
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Ensysce Biosciences has renewed its collaboration with Quotient Sciences to advance the clinical development of its overdose protection platform, PF614-MPAR. This innovative opioid product, designed to prevent overdose by shutting off opioid release when too many pills are ingested, is undergoing a Phase 1b study to evaluate its efficacy a...
.90 promised??
Benzinga· 4 mins ago